Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics.
about
Dopamine covalently modifies and functionally inactivates parkinThe associations between Parkinson's disease and cancer: the plot thickensFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesManganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic EvidenceCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseBiology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorderNorepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleusThe effects of oxidative stress on parkin and other E3 ligases.Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's diseaseAlpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.The 1-Tosylpentan-3-one Protects against 6-Hydroxydopamine-Induced NeurotoxicityThe surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface.Expression of varicella-zoster virus immediate-early regulatory protein IE63 in neurons of latently infected human sensory ganglia.Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.Tracemetals, neuromelanin and neurodegeneration: An interesting area for researchNeuromelanin is an immune stimulator for dendritic cells in vitro.Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging.Magnetic resonance imaging of the substantia nigra in Parkinson's disease.Neuromelanin inhibits CXCL10 expression in human astroglial cells.Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.Role of oxidative stress in Parkinson's disease.The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation.The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speedModifications of the iron-neuromelanin system in Parkinson's disease.The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during agingX-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neuronsWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.Human neuromelanin: an endogenous microglial activator for dopaminergic neuron deathNicotinic receptors as CNS targets for Parkinson's diseaseIn vivo mapping of the human locus coeruleus.The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease.Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease.Alpha-synuclein and Parkinson's disease: a proteomic view.A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin ImagingNeuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP.Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson's Disease.Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
P2860
Q24338423-A8A48C4D-D890-4A45-A649-609D9325F35BQ26778641-85A6B46D-801C-403B-BE3A-42CED41EA64FQ26779933-7926688B-7E81-4898-9C7B-055C978B1C07Q26798261-64A1A67D-A1BA-4BEE-9E73-DF17B020E72AQ26849232-268F6D8C-5025-4E2F-ABF9-5872561BD9F9Q28391762-92CDED9B-8EA3-4B69-924B-0EEDC83A46CCQ28392275-74A5A607-11B7-4DFF-B7F5-8DC52A5621FCQ28831116-637D6582-85D5-426D-9689-022DE945A990Q30273796-4375CA4D-499D-4C2C-979E-573ED6E4E608Q30537842-627D26F2-B9DD-45E4-8D8B-D678075195CDQ30856480-BF7DC8DA-03BB-4859-B2EA-836A7DE04299Q32176923-3721D42A-E290-401E-909E-E58EA415CDEAQ33258374-D5799133-69DB-437C-9136-88F506AB4352Q33725690-D25D5295-BF59-464C-A7BF-7A26DA861B58Q33850589-D74FB878-A8A4-4F99-BB0A-7CE2BED3C4F9Q33984927-3C9F16E6-E51B-4BC2-AAE4-EFE8D90A020EQ34074838-0519220B-39E4-4785-8B4F-60FF5DFD6C7AQ34102325-C196FD70-26D4-44FA-85AA-4263D20165D5Q34287154-5D35ED6D-B156-497F-A180-EA707F5DA070Q34330789-EDEAF656-6490-4D6C-832F-C40AA48D0529Q34337802-D6ADBEE1-8A39-4772-ABE3-487079F05698Q34339252-D3BD1DFA-3B92-4059-878B-B6D023C27C5AQ35029070-97BC3D6C-6A97-4962-96C7-2CA090D2536EQ35104866-9EEBA159-52C0-44AB-BF68-5B28F11174B8Q35545150-F17B4B7B-6049-4EC5-B139-C50E2B0D3DFFQ35726654-2A27109A-4BFB-4F05-AEFC-D6B357461098Q36370608-3CBFEDB2-FE73-4B7F-939C-676CE5BE67C6Q36449196-F9B63E61-8F38-4E25-BA47-83A2556F3DB3Q36583842-D97B6F87-C738-483F-A351-4C924CFAEF59Q36692860-4CD062E1-889E-47E3-A5F6-B4F5560ECBB3Q36766407-AA3A02BD-32A5-42AF-BC55-CCCFE84F7838Q36882136-D50E0D46-FC8E-4F47-A0B3-B61E7DB94986Q36899049-D0182B05-7F55-4E42-9167-B04F8AA6DB93Q36953865-AA3E36E8-BDED-4397-8979-C170BA0F87F8Q37126849-07963E83-043F-4E42-BEDB-10E19DBD80A7Q37157838-56F1D6C5-6A97-4B17-94EB-93FB06E42317Q37223082-E3A916B3-1CF7-47E1-8207-B83AAB8A30EBQ37256315-F34FB6E6-D55B-4A62-AEB7-5F9BD1340B6CQ37352812-D08723E9-8425-404E-B674-B4BAC55CB2F0Q37395786-DBA0F0AF-92FC-4FD3-9998-857A3EA09F54
P2860
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Neuromelanin of the substantia ...... ive and toxic characteristics.
@ast
Neuromelanin of the substantia ...... ive and toxic characteristics.
@en
type
label
Neuromelanin of the substantia ...... ive and toxic characteristics.
@ast
Neuromelanin of the substantia ...... ive and toxic characteristics.
@en
prefLabel
Neuromelanin of the substantia ...... ive and toxic characteristics.
@ast
Neuromelanin of the substantia ...... ive and toxic characteristics.
@en
P2093
P1476
Neuromelanin of the substantia ...... ive and toxic characteristics.
@en
P2093
Fabio A Zucca
Henrik Wilms
Luigi Zecca
P304
P356
10.1016/J.TINS.2003.08.009
P50
P577
2003-11-01T00:00:00Z